Type 2 Diabetes - Stomach Surgery for Weight Loss May Protect Against Heart and Blood Vessel Disease

Much has been written about stomach surgery for reducing weight and preventing or treating Type 2 diabetes. Researchers at the University of Rome have found more good news. Their investigation reported in the medical journal Obesity Surgery in November of 2016, linked sleeve gastrectomy, a surgical procedure created as an aid for  weight   loss , with a lowered risk of developing heart and blood vessel disease.

People who underwent the procedure achieved not only the expected amount of  weight   loss  but also an improvement in the state of their arteries. It was found the carotid arteries which feed blood to the head and brain, had more interior space and were able to open wider after a sleeve gastrectomy. Getting a sufficient blood supply containing oxygen and sugar to the brain prevents strokes.

Sleeve gastrectomy involves cutting away about 75 to 85 percent of the stomach. The result is a much thinner tube that resembles a sleeve. A feeling of early fullness makes it easy to follow a low-calorie diet. The procedure also lowers the release of ghrelin, the hunger hormone. The process can be carried out laparoscopically, with only six incisions into the abdomen. The surgeon can view the stomach through a laparoscope, a long metal instrument with a light on the end. Making six small cuts instead of one large one minimizes recovery time, blood loss, and scarring. None of the intestines is removed or bypassed, so absorption of nutrients is the same.

As with any surgical procedure, there are risks...

  • bleeding, blood clots, and infection,
  • the leakage of stomach contents into the abdominal cavity,
  • nausea, which can be permanent if there is damage to the vagal nerve,
  • vomiting,
  • a delay in emptying the stomach contents into the small intestine,
  • spasm and pain above the stomach,
  • Gastroesophageal reflux disease (GERD), with sharp chest pain.
  • a fast heart beat.

In July of 2016, the journal Surgery for Obesity and Related Diseases reported on a bariatric ( weight   loss ) study carried out at the Cleveland Clinic in the United States. Among 1300 people with Type 2 diabetes having had either a sleeve gastrectomy or roux-en-Y gastric bypass, fewer than half of one percent suffered from most major complications. The exception was bleeding, with 1.7 percent. Both procedures were equally safe. Interestingly, not all the participants were obese. Their body mass indexes, or BMIs, ranged from 25 to under 35. A BMI from 25 to 29.9 indicates a person is overweight, and over 30 is considered obese.